Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Brain Cancer treatment details. Chemotherapy. University of Tubingen, Tubingen, Germany



Survival: 6.9 months
   
Toxicity Grade:
   
Treatments: Chemotherapy
   
Drugs: Cytoxan
Methotrexate
Country: Germany
   
City/State/Province: Tubingen
   
Hospital: University of Tubingen
   
Journal: Link
   
Date: 2/2005

Description:
Patients: This trial involved 10 patients with relapsed glioblastoma. There were 4 men and 6 women, and the median age was 45.

Treatment: The treatment consisted of two chemotherapeutic drugs: methotrexate and cyclophosphamide.

Toxicity: Toxicities were not reported in this study.

Results: The median overall survival was 6.9 months. Since the progression-free survival at 6 months was 0%, the study was prematurely closed. The authors concluded that the treatment was not effective for this population.

Correspondence: Ulrich Herrlinger, MD

E-mail to a Friend Email Physician More Information